Mostrando 541 - 560 Resultados de 56,791 Para Buscar '"pneumonia"', tiempo de consulta: 0.23s Limitar resultados
  1. 541
    “…OBJECTIVE: To identify the difference in clinical characteristics between viral pneumonia and Mycoplasma pneumoniae, providing cues on their differential diagnosis for primary hospitals with the insufficient pathogen detection capacity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 542
  3. 543
    “…OBJECTIVE: This research aimed to investigate the variations in clinical features and prognosis of HABP caused by E. coli and K. pneumoniae. We also aimed to evaluate the risk variables related to 30-day death in the investigated groups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 544
    “…Background: Childhood refractory mycoplasma pneumoniae (MP) pneumonia (RMPP) is a lung disease with elevated level of C-reactive protein and severe clinical and radiological deterioration. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 545
    “…BACKGROUND: Refractory mycoplasma pneumoniae pneumonia (RMPP) is a serious mycoplasma pneumoniae infection and is difficult to diagnose early. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 546
    “…BACKGROUND: To examine the clinical impact of bronchoscope alveolar lavage (BAL) combination with budesonide, ambroxol + budesonide, or acetylcysteine + budesonide in the treatment of refractory Mycoplasma pneumoniae pneumonia (RMPP). METHODS: Eighty-two RMPP patients admitted to Pediatrics at The First People’s Hospital of Zhengzhou were retrospectively evaluated between August 2016 and August 2019. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 547
    “…BACKGROUNDS: Refractory Mycoplasma pneumoniae pneumonia (RMPP) cause damage of pulmonary function and physical therapy assisting medical treatment is needed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 548
    por Xu, Limin, Fang, Changquan
    Publicado 2023
    “…Omadacycline is a novel tetracycline antibiotic that exhibits good in vitro antibacterial activity against atypical pathogens such as Mycoplasma pneumoniae. It is approved for the treatment of adults with community-acquired bacterial pneumonia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 549
    “…BACKGROUND: This study investigates the correlation between coagulation levels and the severity of Mycoplasma pneumoniae pneumonia (MPP) in children. In addition, the study analyses the predictive value of coagulation abnormalities in MPP combined with necrotising pneumonia (NP). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 550
    “…BACKGROUND: We analyzed the clinical characteristics of children with plastic bronchitis (PB) caused by Mycoplasma pneumoniae (MP) and explored its risk factors. METHODS: We prospectively analyzed clinical data of children with MP pneumonia (MPP) treated with fiberoptic bronchoscopy (FB). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 551
    por Cecil, Russell L., Blake, Francis G.
    Publicado 1920
    “…In general, the process closely resembles uncomplicated Bacillus influenzæ pneumonia in man. 3. The injection of virulent influenza bacilli directly into the trachea of monkeys induces in them an experimental bronchiolitis and hemorrhagic bronchopneumonia, similar in all respects to spontaneous Bacillus influenzæ pneumonia. 4. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  12. 552
    por Cecil, Russell L., Blake, Francis G.
    Publicado 1920
    “…The subcutaneous inoculation of monkeys with Pneumococcus Type I vaccine in doses comparable with those employed in man does not protect them against subsequent attacks of Pneumococcus Type I pneumonia, either spontaneous or experimental. Furthermore, the occurrence of Pneumococcus Type IV pneumonia among monkeys that have been vaccinated with Pneumococcus Type I lipovaccine indicates that the vaccinated animals develop no cross-protection against other types of pneumonia. 2. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  13. 553
    por Cecil, Russell L., Blake, Francis G.
    Publicado 1920
    “…A certain amount of cross-immunity against the other fixed types of pneumococcus pneumonia may or may not be present following experimental Pneumococcus Type I pneumonia. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  14. 554
    por Harford, Carl G., Hara, Mary
    Publicado 1950
    “…Conditions in human beings that are known to be complicated by pulmonary edema are also known to be associated with increased susceptibility to secondary bacterial pneumonia.…”
    Enlace del recurso
    Enlace del recurso
    Texto
  15. 555
    “…We evaluated the effect of nebulized anticoagulants on pulmonary coagulopathy and inflammation in a rat model of Streptococcus pneumoniae pneumonia. METHODS: In this randomized controlled in vivo laboratory study rats were challenged intratracheally with S. pneumoniae, inducing pneumonia, and randomized to treatment with normal saline (placebo), recombinant human activated protein C (rh-APC), plasma-derived antithrombin (AT), heparin or danaparoid, by means of nebulization. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  16. 556
    “…INTRODUCTION: Lipoid pneumonia is a rare form of pneumonia caused by inhalation or aspiration of fat containing substances like, petroleum jelly, mineral oils, few laxatives etc. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  17. 557
    “…Mycoplasma pneumoniae and Chlamydia pneumoniae have been suggested to take part in the acute exacerbation of bronchial asthma and chronic obstructive pulmonary disease (COPD). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  18. 558
  19. 559
    “…BACKGROUND: The increasing number of outpatients with multidrug-resistant (MDR) pathogens has led to a new category of pneumonia, termed healthcare-associated pneumonia (HCAP). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 560
Herramientas de búsqueda: RSS